Editorial update on emerging treatments of atopic dermatitis

被引：4

作者：

Ong, Peck Y. ^{[1
]}

机构：

[1] Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Div Clin Immunol & Allergy,Dept Pediat, Los Angeles, CA 90027 USA

来源：

EXPERT OPINION ON EMERGING DRUGS | 2012年 / 17卷 / 02期

关键词：

atopic dermatitis; IL-22; S; aureus; therapy; STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL PEPTIDES; IL-22; KERATINOCYTES; IMMUNITY; SKIN;

D O I：

10.1517/14728214.2012.668884

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Various new agents are in the research pipeline for atopic dermatitis. These include IL-4 receptor antagonist, cis-urocanic acid, kappa-opiod receptor agonist, neurokinin receptor antagonist and antimicrobial peptide. The current review updates the status of these clinical trials and provides insight into other potential molecular targets including IL-22 and TLR-2.

引用

页码：129 / 133

页数：5

共 20 条

[11] IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells
Nograles, Kristine E.
Zaba, Lisa C.
Shemer, Avner
Fuentes-Duculan, Judilyn
Cardinale, Irma
Kikuchi, Toyoko
Ramon, Michal
Bergman, Reuven
Krueger, James G.
Guttman-Yassky, Emma
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (06) : 1244 - 1252
[12] Emerging drugs for atopic dermatitis
Ong, Peck Y.
[J]. EXPERT OPINION ON EMERGING DRUGS, 2009, 14 (01) : 165 - 179
[13] Endogenous antimicrobial peptides and skin infections in atopic dermatitis
Ong, PY
Ohtake, T
Brandt, C
Strickland, I
Boguniewicz, M
Ganz, T
Gallo, RL
Leung, DYM
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (15) : 1151 - 1160
[14] Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis
Paternoster, Lavinia
Standl, Marie
Chen, Chih-Mei
Ramasamy, Adaikalavan
Bonnelykke, Klaus
Duijts, Liesbeth
Ferreira, Manuel A.
Alves, Alexessander Couto
Thyssen, Jacob P.
Albrecht, Eva
Baurecht, Hansjoerg
Feenstra, Bjarke
Sleiman, Patrick M. A.
Hysi, Pirro
Warrington, Nicole M.
Curjuric, Ivan
Myhre, Ronny
Curtin, John A.
Groen-Blokhuis, Maria M.
Kerkhof, Marjan
Saaf, Annika
Franke, Andre
Ellinghaus, David
Foelster-Holst, Regina
Dermitzakis, Emmanouil
Montgomery, Stephen B.
Prokisch, Holger
Heim, Katharina
Hartikainen, Anna-Liisa
Pouta, Anneli
Pekkanen, Juha
Blakemore, Alexandra I. F.
Buxton, Jessica L.
Kaakinen, Marika
Duffy, David L.
Madden, Pamela A.
Heath, Andrew C.
Montgomery, Grant W.
Thompson, Philip J.
Matheson, Melanie C.
Le Souef, Peter
St Pourcain, Beate
Smith, George Davey
Henderson, John
Kemp, John P.
Timpson, Nicholas J.
Deloukas, Panos
Ring, Susan M.
Wichmann, H-Erich
Mueller-Nurasyid, Martina
[J]. NATURE GENETICS, 2012, 44 (02) : 187 - 192
[15] Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis
Schlievert, Patrick M.
Strandberg, Kristi L.
Lin, Ying-Chi
Peterson, Marnie L.
Leung, Donald Y. M.
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (01) : 39 - 49
[16] The role of keratinocytes in defense against infection
Schroeder, Jens-Michael
[J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2010, 23 (02) : 106 - 110
[17] Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A
Sonnenberg, Gregory F.
Nair, Meera G.
Kirn, Thomas J.
Zaph, Colby
Fouser, Lynette A.
Artis, David
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 207 (06) : 1293 - 1305
[18] Targeting the Neurokinin Receptor 1 with Aprepitant: A Novel Antipruritic Strategy
Staender, Sonja
Siepmann, Dorothee
Herrgott, Ilka
Sunderkoetter, Cord
Luger, Thomas A.
[J]. PLOS ONE, 2010, 5 (06):
[19] Travers JB, 2011, PEDIAT DERMATOL
[20] IL-22 increases the innate immunity of tissues
Wolk, K
Kunz, S
Witte, E
Friedrich, M
Asadullah, K
Sabat, R
[J]. IMMUNITY, 2004, 21 (02) : 241 - 254

← 1 2 →